Giant pancreatic insulinoma. The bigger the worse? Report of two cases and literature review
Authors:
- Benedetto IelpoBenedetto Ielpo
- Riccardo CarusoRCRiccardo Caruso
- Valentina FerriVFValentina Ferri
- Yolanda QuijanoYQYolanda Quijano
- Hipolito DuranHDHipolito Duran
- Eduardo DiazEDEduardo Diaz
- Isabel FabraIFIsabel Fabra
- Ramon PugaRPRamon Puga
- Catalina OlivaCOCatalina Oliva
- Sergio OlivaresSOSergio Olivares
- Emilio VicenteEVEmilio Vicente
Open Access
- 1 January 2013
- journal article
- research article
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 4 (3) , 265-268
Abstract
INTRODUCTION: Giant pancreatic insulinomas are rare endocrine tumors. We describe 2 cases reviewing the current literature. PRESENTATION OF CASE: We report herein 2 female patients affected by giant insulinomas of 14 cm and 6 cm, respectively. Symptomatic hypoglycemia episodes occurred during 4 months in first case and 3 years in the second one until diagnosis. Both patients were successfully treated performing a distal pancreatectomy with splenic preservation in the first case and a Whipple’s procedure in the second one. DISCUSSION: Up to now only 7 cases have been reported previously. Insulinomas larger than 3 cm accounts for less than 5% of all. This literature review shows that despite the size hypoglycemic symptoms varies from 1 day to 3 years and only 1 out of 9 cases reported presented lymph nodes metastases. No recurrences have been described. CONCLUSION: One of the cases here described (14 cm) is the largest presented in the literature. Despite the size, giant insulinoma is related apparently neither to metastases nor to the recurrences.Keywords
This publication has 15 references indexed in Scilit:
- Neuroendocrine neoplasms of the gut and pancreas: new insightsNature Reviews Endocrinology, 2011
- Giant Pancreatic Tumor With Clinical Characteristics of Insulinoma But Without Common Pathologic FeaturesEndocrine Practice, 2011
- The NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine TumorsPancreas, 2010
- The management of insulinomaBritish Journal of Surgery, 2006
- Malignant insulinomaCancer, 2005
- Giant Insulinoma: Case Report and Review of the LiteratureThe Journal of Clinical Endocrinology & Metabolism, 2005
- Functioning Insulinoma—Incidence, Recurrence, and Long-Term Survival of Patients: A 60-Year StudyMayo Clinic Proceedings, 1991
- Pathogenesis of Hypoglycemia in Insulinoma Patients: Suppression of Hepatic Glucose Production by InsulinDiabetes, 1981
- Giant insulinomaThe American Journal of Surgery, 1976
- ADENOMA OF ISLET CELLS WITH HYPERINSULIXISMAnnals of Surgery, 1935